Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q4 2015 13F Holders as of 31 Dec 2015
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 6,732,938
- Share change
- -377,335
- Total reported value
- $16,753,741
- Price per share
- $2.47
- Number of holders
- 14
- Value change
- -$1,105,844
- Number of buys
- 7
- Number of sells
- 3
Report period
Q4 2015
Institutions
14
Top holders
10
AUPH full security history
Newer quarter: Q1 2016
Previous quarter: Q3 2015
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05156V102
Recent filing periods:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
1.9%
|
2,546,843
|
$7,233,000 | — | 30 Sep 2015 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.8%
|
2,457,144
|
$6,917,000 | — | 30 Sep 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.54%
|
711,499
|
$1,999,000 | — | 30 Sep 2015 | |
| EverPoint Asset Management, LLC |
13F
|
Company |
0.5%
|
659,210
|
$1,872,000 | — | 30 Sep 2015 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.28%
|
377,427
|
$1,072,000 | — | 30 Sep 2015 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
145,200
|
$412,000 | — | 30 Sep 2015 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.08%
|
110,313
|
$314,000 | — | 30 Sep 2015 | |
| Cheyne Capital Management (UK) LLP |
13F
|
Company |
0.07%
|
90,000
|
$257,000 | — | 30 Sep 2015 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
11,037
|
$31,000 | — | 30 Sep 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 30 Sep 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
600
|
$2,000 | — | 30 Sep 2015 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2015
As of 31 Dec 2015,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,732,938 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, EverPoint Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, Lombard Odier Asset Management (USA) Corp, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Redmile Group, LLC, and ROYAL BANK OF CANADA.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2015 vs Q3 2015 Across Filers
Q3 2015 holders
11
Q4 2015 holders
14
Holder diff
3
| Investor | Q3 2015 Shares | Q4 2015 Shares | Share Diff | Share Chg % | Q3 2015 Value $ | Q4 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.